Literature DB >> 10721355

Nature, nurture and my experience with smallpox eradication.

F Fenner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10721355     DOI： 10.5694/j.1326-5377.1999.tb123833.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  5 in total

1.  Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently.

Authors:  Justin W Ady; Jacqueline Heffner; Kelly Mojica; Clark Johnsen; Laurence J Belin; Damon Love; Chin-Tung Chen; Amudhan Pugalenthi; Elizabeth Klein; Nanhai G Chen; Yong A Yu; Aladar A Szalay; Yuman Fong
Journal:  Surgery       Date:  2014-06-21       Impact factor: 3.982

2.  Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer.

Authors:  Sepideh Gholami; Chun-Hao Chen; Laurence J Belin; Emil Lou; Sho Fujisawa; Caroline Antonacci; Amanda Carew; Nanhai G Chen; Marina De Brot; Pat B Zanzonico; Aladar A Szalay; Yuman Fong
Journal:  Breast Cancer Res       Date:  2013-03-18       Impact factor: 6.466

3.  Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.

Authors:  Amudhan Pugalenthi; Kelly Mojica; Justin W Ady; Clark Johnsen; Damon Love; Nanhai G Chen; Richard J Aguilar; Aladar A Szalay; Yuman Fong
Journal:  Cancer Gene Ther       Date:  2015-11-20       Impact factor: 5.987

4.  Challenges to global measles eradication: is it all in the timing?

Authors:  Robert Davis; William Baguma Mbabazi
Journal:  Pan Afr Med J       Date:  2017-06-21

5.  Postcolonial Ecologies of Parasite and Host: Making Parasitism Cosmopolitan.

Authors:  Warwick Anderson
Journal:  J Hist Biol       Date:  2016-04       Impact factor: 0.818
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.